Former nuclear weapons plant staffers testified in Tampa about the years they’ve waited for long-promised financial help.

An advisory panel for the U.S. Food and Drug Administration on Wednesday recommended the approval of a blood test designed to detect various cancers in their early stages. The test, manufactured by ...

"Genialis and Inventia to enhance pancreatic cancer treatment testing" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The figure was announced during a ...

September is Gynecological Cancer Awareness Month. Cervical cancer is the fourth most common cancer among women, with 60,000 new cases of the disease in 2022.

Federal health advisers endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it's far from clear how well the technology works.

Crystal Jones Woodard was diagnosed with an aggressive form of breast cancer in 2018. Even as she fought for her own life, her focus remained on helping others.

Addressing the growing burden of cancer and global disparities in cancer diagnosis and treatment requires innovative, multi-sectoral solutions that go beyond traditional partnerships. On the margins ...

The FDA is expected to make its final ruling on Galleri’s premarket approval in the coming months.

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers ...

Galleri multi-cancer early detection test's premarket approval application received a favorable vote from the Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee of ...

A panel of outside experts advising the US FDA said ​on Wednesday the benefits of Grail's blood-based cancer detection test outweigh ‌its risks, paving the way for a potential landmark approval in ...